Mylan stock bounces back from early losses after CEO blames FDA for drug delays

Mylan’s stock bounced back in midday trading Wednesday from lower-than-expected second quarter earnings after the company’s management said its generic drug Advair is not being delayed by further FDA-required studies. After shares of the drug-maker dropped...

Maryland City May Let Noncitizens Vote, a Proposal With Precedent

By MAGGIE ASTOR August 9, 2017 As a federal commission searches for evidence of voter fraud and many states try to impose new voting restrictions, a city in Maryland may move in the opposite direction: allowing noncitizens to vote in local elections. In...

The September surprises that could be spookier for markets than North Korea

The escalating war of words between the U.S. and North Korea is nerve wracking, but other events like a possible debt ceiling crisis and a hawkish Federal Reserve could create a bigger reaction in financial markets. Stocks have been in a slow drift higher this summer,...

Beneath Markets’ Calm Are Signs of Growing Investor Caution

By LANDON THOMAS Jr. August 9, 2017 President Trump threatened nuclear war with North Korea, and the markets yawned. While stocks in Asia sold off initially, the main market measures in the United States were off less than half a percent on Wednesday as...